Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis
M Umesawa, G Kobashi - Hypertension Research, 2017 - nature.com
Hypertensive disorders in pregnancy (HDP) represent some of the most important problems
faced by public health because HDP is a major cause of maternal and prenatal morbidity …
faced by public health because HDP is a major cause of maternal and prenatal morbidity …
[HTML][HTML] Classical renin-angiotensin system in kidney physiology
MA Sparks, SD Crowley, SB Gurley… - Comprehensive …, 2014 - ncbi.nlm.nih.gov
The renin-angiotensin system has powerful effects in control of the blood pressure and
sodium homeostasis. These actions are coordinated through integrated actions in the …
sodium homeostasis. These actions are coordinated through integrated actions in the …
Essential hypertension: part I: definition and etiology
OA Carretero, S Oparil - Circulation, 2000 - Am Heart Assoc
Although it has frequently been indicated that the causes of essential hypertension are not
known, this is only partially true because we have little information on genetic variations or …
known, this is only partially true because we have little information on genetic variations or …
Molecular mechanisms of human hypertension
RP Lifton, AG Gharavi, DS Geller - Cell, 2001 - cell.com
Hypertension, or elevated arterial blood pressure, is a been operationally defined as the
blood pressure level substantial public health problem, affecting 25% of the above which …
blood pressure level substantial public health problem, affecting 25% of the above which …
Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases
P Meneton, X Jeunemaitre… - Physiological …, 2005 - journals.physiology.org
Epidemiological, migration, intervention, and genetic studies in humans and animals
provide very strong evidence of a causal link between high salt intake and high blood …
provide very strong evidence of a causal link between high salt intake and high blood …
Disease-associated mutations that alter the RNA structural ensemble
M Halvorsen, JS Martin, S Broadaway… - PLoS genetics, 2010 - journals.plos.org
Genome-wide association studies (GWAS) often identify disease-associated mutations in
intergenic and non-coding regions of the genome. Given the high percentage of the human …
intergenic and non-coding regions of the genome. Given the high percentage of the human …
The ACE gene and human performance: 12 years on
Z Puthucheary, JRA Skipworth, J Rawal, M Loosemore… - Sports medicine, 2011 - Springer
Some 12 years ago, a polymorphism of the angiotensin I-converting enzyme (ACE) gene
became the first genetic element shown to impact substantially on human physical …
became the first genetic element shown to impact substantially on human physical …
Host genetic factors influence disease progression in chronic hepatitis C
EE Powell, CJ Edwards-Smith, JL Hay, AD Clouston… - Hepatology, 2000 - journals.lww.com
Progressive hepatic fibrosis and cirrhosis develops in 20% to 30% of patients with chronic
hepatitis C virus (HCV). We propose that host genetic factors influencing fibrogenesis may …
hepatitis C virus (HCV). We propose that host genetic factors influencing fibrogenesis may …
Renin-angiotensin system gene polymorphisms and atrial fibrillation
CT Tsai, LP Lai, JL Lin, FT Chiang, JJ Hwang… - Circulation, 2004 - Am Heart Assoc
Background—The activated local atrial renin-angiotensin system (RAS) has been reported
to play an important role in the pathogenesis of atrial fibrillation (AF). We hypothesized that …
to play an important role in the pathogenesis of atrial fibrillation (AF). We hypothesized that …
A redox switch in angiotensinogen modulates angiotensin release
A Zhou, RW Carrell, MP Murphy, Z Wei, Y Yan… - Nature, 2010 - nature.com
Blood pressure is critically controlled by angiotensins, which are vasopressor peptides
specifically released by the enzyme renin from the tail of angiotensinogen—a non-inhibitory …
specifically released by the enzyme renin from the tail of angiotensinogen—a non-inhibitory …